Nutritional Supplement for Sickle Cell Anemia Energy and Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sickle cell disease primarily focus on managing symptoms and do not effectively address the underlying nutritional deficiencies and high energy requirements of patients, leading to chronic complications and shortened life expectancy.
Innovation Solution
A nutritional supplement providing 700-980 kcal with 10-20% protein, 25-40% fat, and 45-65% carbohydrates, including specific amino acids and antioxidants, administered orally to support energy metabolism and address malnutrition and inflammation in sickle cell anemia patients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional vitamin and mineral supplements are administered to sickle cell patients, then erythropoiesis is normalized and HbF production increases, but the high energy requirements and oxidative stress associated with the disease are not addressed
Solution Approach 1:
The patent combines multiple nutritional components (vitamins, minerals, amino acids, antioxidants, and high-calorie substrates) into a single comprehensive nutritional composition. This merging approach allows simultaneous addressing of erythropoiesis support, energy requirements, and oxidative stress reduction that cannot be achieved with traditional single-component supplements
Solution Approach 2:
The nutritional composition is designed to perform multiple functions: providing high calories for energy requirements, supplying amino acids for protein synthesis and erythropoiesis, including antioxidants for oxidative stress reduction, and providing vitamins and minerals for overall metabolic support. This multi-functionality addresses various aspects of sickle cell disease with a single intervention
2Reliability
If bone marrow transplant is performed as the only cure for sickle cell disease, then the disease is cured, but availability is extremely limited and not widely accessible
Solution Approach 1:
The patent employs an oral nutritional composition that can be administered repeatedly over time as a cost-effective, accessible alternative to bone marrow transplant. This disposable-style approach (repeated oral administration) provides therapeutic benefits without requiring complex, expensive, and limited transplant procedures, making treatment accessible to a broader population
3Reliability
If hydroxyurea is administered to increase fetal hemoglobin production, then HbF levels increase and polymerization is reduced, but bone marrow suppression occurs as a negative side effect
Solution Approach 1:
The patent converts the harmful effect of oxidative stress and inflammation in sickle cell disease into a beneficial therapeutic opportunity by incorporating specific antioxidants (vitamin C, vitamin E, beta-carotene, selenium) and anti-inflammatory nutrients. These components counteract the oxidative damage that would otherwise worsen the disease, while supporting healthy red blood cell production through amino acids and vitamins
Data Source
AI summary
A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement.